|
| | 103RD GENERAL ASSEMBLY
State of Illinois
2023 and 2024 SB3797 Introduced 2/9/2024, by Sen. Christopher Belt SYNOPSIS AS INTRODUCED: | | 410 ILCS 130/10 | | 410 ILCS 130/103 new | | 410 ILCS 705/5-22 new | | 410 ILCS 705/15-40 | | 410 ILCS 130/100 rep. | | 410 ILCS 130/120 rep. | |
| Amends the Compassionate Use of Medical Cannabis Program Act. Provides that the Department of Agriculture shall follow specified requirements of the Cannabis Regulation and Tax Act regarding the administration of cultivation center agent identification cards. Repeals provisions regarding cultivation center agent identification cards and dispensing organization agent identification cards. Makes other changes. Amends the Cannabis Regulation and Tax Act. Provides that the Department of Agriculture and the Department of Financial and Professional Regulation shall issue all agent identification cards under the Act via an online application portal. Provides that all notifications of acceptance or denial for applications under specified provisions shall be sent directly to the agent applicant. |
| |
| | A BILL FOR |
|
|
| | SB3797 | | LRB103 38981 CES 69118 b |
|
|
1 | | AN ACT concerning health. |
2 | | Be it enacted by the People of the State of Illinois, |
3 | | represented in the General Assembly: |
4 | | Section 5. The Compassionate Use of Medical Cannabis |
5 | | Program Act is amended by changing Section 10 and by adding |
6 | | Section 103 as follows: |
7 | | (410 ILCS 130/10) |
8 | | Sec. 10. Definitions. The following terms, as used in this |
9 | | Act, shall have the meanings set forth in this Section: |
10 | | (a) "Adequate supply" means: |
11 | | (1) 2.5 ounces of usable cannabis during a period of |
12 | | 14 days and that is derived solely from an intrastate |
13 | | source. |
14 | | (2) Subject to the rules of the Department of Public |
15 | | Health, a patient may apply for a waiver where a |
16 | | certifying health care professional provides a substantial |
17 | | medical basis in a signed, written statement asserting |
18 | | that, based on the patient's medical history, in the |
19 | | certifying health care professional's professional |
20 | | judgment, 2.5 ounces is an insufficient adequate supply |
21 | | for a 14-day period to properly alleviate the patient's |
22 | | debilitating medical condition or symptoms associated with |
23 | | the debilitating medical condition. |
|
| | SB3797 | - 2 - | LRB103 38981 CES 69118 b |
|
|
1 | | (3) This subsection may not be construed to authorize |
2 | | the possession of more than 2.5 ounces at any time without |
3 | | authority from the Department of Public Health. |
4 | | (4) The pre-mixed weight of medical cannabis used in |
5 | | making a cannabis infused product shall apply toward the |
6 | | limit on the total amount of medical cannabis a registered |
7 | | qualifying patient may possess at any one time. |
8 | | (a-5) "Advanced practice registered nurse" means a person |
9 | | who is licensed under the Nurse Practice Act as an advanced |
10 | | practice registered nurse and has a controlled substances |
11 | | license under Article III of the Illinois Controlled |
12 | | Substances Act. |
13 | | (b) "Cannabis" has the meaning given that term in Section |
14 | | 3 of the Cannabis Control Act. |
15 | | (c) "Cannabis plant monitoring system" means a system that |
16 | | includes, but is not limited to, testing and data collection |
17 | | established and maintained by the registered cultivation |
18 | | center and available to the Department for the purposes of |
19 | | documenting each cannabis plant and for monitoring plant |
20 | | development throughout the life cycle of a cannabis plant |
21 | | cultivated for the intended use by a qualifying patient from |
22 | | seed planting to final packaging. |
23 | | (d) "Cardholder" means a qualifying patient or a |
24 | | designated caregiver who has been issued and possesses a valid |
25 | | registry identification card by the Department of Public |
26 | | Health. |
|
| | SB3797 | - 3 - | LRB103 38981 CES 69118 b |
|
|
1 | | (d-5) "Certifying health care professional" means a |
2 | | physician, an advanced practice registered nurse, or a |
3 | | physician assistant. |
4 | | (e) "Cultivation center" means a facility operated by an |
5 | | organization or business that is registered by the Department |
6 | | of Agriculture to perform necessary activities to provide only |
7 | | registered medical cannabis dispensing organizations with |
8 | | usable medical cannabis. |
9 | | (f) "Cultivation center agent" means a principal officer, |
10 | | board member, employee, or agent of a registered cultivation |
11 | | center who is 21 years of age or older and has not been |
12 | | convicted of an excluded offense. |
13 | | (g) "Cultivation center agent identification card" means a |
14 | | document issued by the Department of Agriculture that |
15 | | identifies a person as a cultivation center agent. |
16 | | (h) "Debilitating medical condition" means one or more of |
17 | | the following: |
18 | | (1) cancer, glaucoma, positive status for human |
19 | | immunodeficiency virus, acquired immune deficiency |
20 | | syndrome, hepatitis C, amyotrophic lateral sclerosis, |
21 | | Crohn's disease (including, but not limited to, ulcerative |
22 | | colitis), agitation of Alzheimer's disease, |
23 | | cachexia/wasting syndrome, muscular dystrophy, severe |
24 | | fibromyalgia, spinal cord disease, including but not |
25 | | limited to arachnoiditis, Tarlov cysts, hydromyelia, |
26 | | syringomyelia, Rheumatoid arthritis, fibrous dysplasia, |
|
| | SB3797 | - 4 - | LRB103 38981 CES 69118 b |
|
|
1 | | spinal cord injury, traumatic brain injury and |
2 | | post-concussion syndrome, Multiple Sclerosis, |
3 | | Arnold-Chiari malformation and Syringomyelia, |
4 | | Spinocerebellar Ataxia (SCA), Parkinson's, Tourette's, |
5 | | Myoclonus, Dystonia, Reflex Sympathetic Dystrophy, RSD |
6 | | (Complex Regional Pain Syndromes Type I), Causalgia, CRPS |
7 | | (Complex Regional Pain Syndromes Type II), |
8 | | Neurofibromatosis, Chronic Inflammatory Demyelinating |
9 | | Polyneuropathy, Sjogren's syndrome, Lupus, Interstitial |
10 | | Cystitis, Myasthenia Gravis, Hydrocephalus, nail-patella |
11 | | syndrome, residual limb pain, seizures (including those |
12 | | characteristic of epilepsy), post-traumatic stress |
13 | | disorder (PTSD), autism, chronic pain, irritable bowel |
14 | | syndrome, migraines, osteoarthritis, anorexia nervosa, |
15 | | Ehlers-Danlos Syndrome, Neuro-Behcet's Autoimmune |
16 | | Disease, neuropathy, polycystic kidney disease, superior |
17 | | canal dehiscence syndrome, or the treatment of these |
18 | | conditions; |
19 | | (1.5) terminal illness with a diagnosis of 6 months or |
20 | | less; if the terminal illness is not one of the qualifying |
21 | | debilitating medical conditions, then the certifying |
22 | | health care professional shall on the certification form |
23 | | identify the cause of the terminal illness; or |
24 | | (2) any other debilitating medical condition or its |
25 | | treatment that is added by the Department of Public Health |
26 | | by rule as provided in Section 45. |
|
| | SB3797 | - 5 - | LRB103 38981 CES 69118 b |
|
|
1 | | (i) "Designated caregiver" means a person who: (1) is at |
2 | | least 21 years of age; (2) has agreed to assist with a |
3 | | patient's medical use of cannabis; (3) has not been convicted |
4 | | of an excluded offense; and (4) assists no more than one |
5 | | registered qualifying patient with his or her medical use of |
6 | | cannabis. |
7 | | (j) "Dispensing organization agent identification card" |
8 | | means a document issued by the Department of Financial and |
9 | | Professional Regulation that identifies a person as a medical |
10 | | cannabis dispensing organization agent , as that term is |
11 | | defined under Section 1-10 of the Cannabis Regulation and Tax |
12 | | Act . |
13 | | (k) "Enclosed, locked facility" means a room, greenhouse, |
14 | | building, or other enclosed area equipped with locks or other |
15 | | security devices that permit access only by a cultivation |
16 | | center's agents or a dispensing organization's agent working |
17 | | for the registered cultivation center or the registered |
18 | | dispensing organization to cultivate, store, and distribute |
19 | | cannabis for registered qualifying patients. |
20 | | (l) "Excluded offense" for cultivation center agents and |
21 | | dispensing organizations means: |
22 | | (1) a violent crime defined in Section 3 of the Rights |
23 | | of Crime Victims and Witnesses Act or a substantially |
24 | | similar offense that was classified as a felony in the |
25 | | jurisdiction where the person was convicted; or |
26 | | (2) a violation of a state or federal controlled |
|
| | SB3797 | - 6 - | LRB103 38981 CES 69118 b |
|
|
1 | | substance law, the Cannabis Control Act, or the |
2 | | Methamphetamine Control and Community Protection Act that |
3 | | was classified as a felony in the jurisdiction where the |
4 | | person was convicted, except that the registering |
5 | | Department may waive this restriction if the person |
6 | | demonstrates to the registering Department's satisfaction |
7 | | that his or her conviction was for the possession, |
8 | | cultivation, transfer, or delivery of a reasonable amount |
9 | | of cannabis intended for medical use. This exception does |
10 | | not apply if the conviction was under state law and |
11 | | involved a violation of an existing medical cannabis law. |
12 | | For purposes of this subsection, the Department of Public |
13 | | Health shall determine by emergency rule within 30 days after |
14 | | the effective date of this amendatory Act of the 99th General |
15 | | Assembly what constitutes a "reasonable amount". |
16 | | (l-5) (Blank). |
17 | | (l-10) "Illinois Cannabis Tracking System" means a |
18 | | web-based system established and maintained by the Department |
19 | | of Public Health that is available to the Department of |
20 | | Agriculture, the Department of Financial and Professional |
21 | | Regulation, the Illinois State Police, and registered medical |
22 | | cannabis dispensing organizations on a 24-hour basis to upload |
23 | | written certifications for Opioid Alternative Pilot Program |
24 | | participants, to verify Opioid Alternative Pilot Program |
25 | | participants, to verify Opioid Alternative Pilot Program |
26 | | participants' available cannabis allotment and assigned |
|
| | SB3797 | - 7 - | LRB103 38981 CES 69118 b |
|
|
1 | | dispensary, and the tracking of the date of sale, amount, and |
2 | | price of medical cannabis purchased by an Opioid Alternative |
3 | | Pilot Program participant. |
4 | | (m) "Medical cannabis cultivation center registration" |
5 | | means a registration issued by the Department of Agriculture. |
6 | | (n) "Medical cannabis container" means a sealed, |
7 | | traceable, food compliant, tamper resistant, tamper evident |
8 | | container, or package used for the purpose of containment of |
9 | | medical cannabis from a cultivation center to a dispensing |
10 | | organization. |
11 | | (o) "Medical cannabis dispensing organization", or |
12 | | "dispensing organization", or "dispensary organization" means |
13 | | a facility operated by an organization or business that is |
14 | | registered by the Department of Financial and Professional |
15 | | Regulation to acquire medical cannabis from a registered |
16 | | cultivation center for the purpose of dispensing cannabis, |
17 | | paraphernalia, or related supplies and educational materials |
18 | | to registered qualifying patients, individuals with a |
19 | | provisional registration for qualifying patient cardholder |
20 | | status, or an Opioid Alternative Pilot Program participant. |
21 | | (p) "Medical cannabis dispensing organization agent" or |
22 | | "dispensing organization agent" means a principal officer, |
23 | | board member, employee, or agent of a registered medical |
24 | | cannabis dispensing organization who is 21 years of age or |
25 | | older and has not been convicted of an excluded offense. |
26 | | (q) "Medical cannabis infused product" means food, oils, |
|
| | SB3797 | - 8 - | LRB103 38981 CES 69118 b |
|
|
1 | | ointments, or other products containing usable cannabis that |
2 | | are not smoked. |
3 | | (r) "Medical use" means the acquisition; administration; |
4 | | delivery; possession; transfer; transportation; or use of |
5 | | cannabis to treat or alleviate a registered qualifying |
6 | | patient's debilitating medical condition or symptoms |
7 | | associated with the patient's debilitating medical condition. |
8 | | (r-5) "Opioid" means a narcotic drug or substance that is |
9 | | a Schedule II controlled substance under paragraph (1), (2), |
10 | | (3), or (5) of subsection (b) or under subsection (c) of |
11 | | Section 206 of the Illinois Controlled Substances Act. |
12 | | (r-10) "Opioid Alternative Pilot Program participant" |
13 | | means an individual who has received a valid written |
14 | | certification to participate in the Opioid Alternative Pilot |
15 | | Program for a medical condition for which an opioid has been or |
16 | | could be prescribed by a certifying health care professional |
17 | | based on generally accepted standards of care. |
18 | | (s) "Physician" means a doctor of medicine or doctor of |
19 | | osteopathy licensed under the Medical Practice Act of 1987 to |
20 | | practice medicine and who has a controlled substances license |
21 | | under Article III of the Illinois Controlled Substances Act. |
22 | | It does not include a licensed practitioner under any other |
23 | | Act including but not limited to the Illinois Dental Practice |
24 | | Act. |
25 | | (s-1) "Physician assistant" means a physician assistant |
26 | | licensed under the Physician Assistant Practice Act of 1987 |
|
| | SB3797 | - 9 - | LRB103 38981 CES 69118 b |
|
|
1 | | and who has a controlled substances license under Article III |
2 | | of the Illinois Controlled Substances Act. |
3 | | (s-5) "Provisional registration" means a document issued |
4 | | by the Department of Public Health to a qualifying patient who |
5 | | has submitted: (1) an online application and paid a fee to |
6 | | participate in Compassionate Use of Medical Cannabis Program |
7 | | pending approval or denial of the patient's application; or |
8 | | (2) a completed application for terminal illness. |
9 | | (t) "Qualifying patient" means a person who has been |
10 | | diagnosed by a certifying health care professional as having a |
11 | | debilitating medical condition. |
12 | | (u) "Registered" means licensed, permitted, or otherwise |
13 | | certified by the Department of Agriculture, Department of |
14 | | Public Health, or Department of Financial and Professional |
15 | | Regulation. |
16 | | (v) "Registry identification card" means a document issued |
17 | | by the Department of Public Health that identifies a person as |
18 | | a registered qualifying patient or registered designated |
19 | | caregiver. |
20 | | (w) "Usable cannabis" means the seeds, leaves, buds, and |
21 | | flowers of the cannabis plant and any mixture or preparation |
22 | | thereof, but does not include the stalks, and roots of the |
23 | | plant. It does not include the weight of any non-cannabis |
24 | | ingredients combined with cannabis, such as ingredients added |
25 | | to prepare a topical administration, food, or drink. |
26 | | (x) "Verification system" means a Web-based system |
|
| | SB3797 | - 10 - | LRB103 38981 CES 69118 b |
|
|
1 | | established and maintained by the Department of Public Health |
2 | | that is available to the Department of Agriculture, the |
3 | | Department of Financial and Professional Regulation, law |
4 | | enforcement personnel, and registered medical cannabis |
5 | | dispensing organization agents on a 24-hour basis for the |
6 | | verification of registry identification cards, the tracking of |
7 | | delivery of medical cannabis to medical cannabis dispensing |
8 | | organizations, and the tracking of the date of sale, amount, |
9 | | and price of medical cannabis purchased by a registered |
10 | | qualifying patient. |
11 | | (y) "Written certification" means a document dated and |
12 | | signed by a certifying health care professional, stating (1) |
13 | | that the qualifying patient has a debilitating medical |
14 | | condition and specifying the debilitating medical condition |
15 | | the qualifying patient has; and (2) that (A) the certifying |
16 | | health care professional is treating or managing treatment of |
17 | | the patient's debilitating medical condition; or (B) an Opioid |
18 | | Alternative Pilot Program participant has a medical condition |
19 | | for which opioids have been or could be prescribed. A written |
20 | | certification shall be made only in the course of a bona fide |
21 | | health care professional-patient relationship, after the |
22 | | certifying health care professional has completed an |
23 | | assessment of either a qualifying patient's medical history or |
24 | | Opioid Alternative Pilot Program participant, reviewed |
25 | | relevant records related to the patient's debilitating |
26 | | condition, and conducted a physical examination. |
|
| | SB3797 | - 11 - | LRB103 38981 CES 69118 b |
|
|
1 | | (z) "Bona fide health care professional-patient |
2 | | relationship" means a relationship established at a hospital, |
3 | | certifying health care professional's office, or other health |
4 | | care facility in which the certifying health care professional |
5 | | has an ongoing responsibility for the assessment, care, and |
6 | | treatment of a patient's debilitating medical condition or a |
7 | | symptom of the patient's debilitating medical condition. |
8 | | A veteran who has received treatment at a VA hospital |
9 | | shall be deemed to have a bona fide health care |
10 | | professional-patient relationship with a VA certifying health |
11 | | care professional if the patient has been seen for his or her |
12 | | debilitating medical condition at the VA Hospital in |
13 | | accordance with VA Hospital protocols. |
14 | | A bona fide health care professional-patient relationship |
15 | | under this subsection is a privileged communication within the |
16 | | meaning of Section 8-802 of the Code of Civil Procedure. |
17 | | (Source: P.A. 100-1114, eff. 8-28-18; 101-363, eff. 8-9-19.) |
18 | | (410 ILCS 130/103 new) |
19 | | Sec. 103. Cultivation center agent identification cards. |
20 | | The Department of Agriculture shall follow the requirements |
21 | | set forth in Section 20-35 of the Cannabis Regulation and Tax |
22 | | Act regarding the administration of cultivation center agent |
23 | | identification cards under this Act. |
24 | | Section 10. The Cannabis Regulation and Tax Act is amended |
|
| | SB3797 | - 12 - | LRB103 38981 CES 69118 b |
|
|
1 | | by adding Section 5-22 and by changing Section 15-40 as |
2 | | follows: |
3 | | (410 ILCS 705/5-22 new) |
4 | | Sec. 5-22. Identification cards. The Department of |
5 | | Agriculture and the Department of Financial and Professional |
6 | | Regulation shall issue all identification cards under this Act |
7 | | via an online application portal. |
8 | | (410 ILCS 705/15-40) |
9 | | Sec. 15-40. Dispensing organization agent identification |
10 | | card; agent training. |
11 | | (a) The Department shall: |
12 | | (1) verify the information contained in an application |
13 | | or renewal for a dispensing organization agent |
14 | | identification card submitted under this Article, and |
15 | | approve or deny an application or renewal, within 30 days |
16 | | of receiving a completed application or renewal |
17 | | application and all supporting documentation required by |
18 | | rule; |
19 | | (2) issue a dispensing organization agent |
20 | | identification card to a qualifying agent within 15 |
21 | | business days of approving the application or renewal; |
22 | | (3) enter the registry identification number of the |
23 | | dispensing organization where the agent works; |
24 | | (4) within one year from the effective date of this |
|
| | SB3797 | - 13 - | LRB103 38981 CES 69118 b |
|
|
1 | | Act, allow for an electronic application process and |
2 | | provide a confirmation by electronic or other methods that |
3 | | an application has been submitted; and |
4 | | (5) collect a $100 nonrefundable fee from the |
5 | | applicant to be deposited into the Cannabis Regulation |
6 | | Fund. |
7 | | (b) A dispensing organization agent must keep his or her |
8 | | identification card visible at all times when in the |
9 | | dispensary. |
10 | | (c) The dispensing organization agent identification cards |
11 | | shall contain the following: |
12 | | (1) the name of the cardholder; |
13 | | (2) the date of issuance and expiration date of the |
14 | | dispensing organization agent identification cards; |
15 | | (3) a random 10-digit alphanumeric identification |
16 | | number containing at least 4 numbers and at least 4 |
17 | | letters that is unique to the cardholder; and |
18 | | (4) a photograph of the cardholder. |
19 | | (d) The dispensing organization agent identification cards |
20 | | shall be immediately returned to the dispensing organization |
21 | | upon termination of employment. |
22 | | (e) The Department shall not issue an agent identification |
23 | | card if the applicant is delinquent in filing any required tax |
24 | | returns or paying any amounts owed to the State of Illinois. |
25 | | (f) Any card lost by a dispensing organization agent shall |
26 | | be reported to the Illinois State Police and the Department |
|
| | SB3797 | - 14 - | LRB103 38981 CES 69118 b |
|
|
1 | | immediately upon discovery of the loss. |
2 | | (g) An applicant shall be denied a dispensing organization |
3 | | agent identification card renewal if he or she fails to |
4 | | complete the training provided for in this Section. |
5 | | (h) A dispensing organization agent shall only be required |
6 | | to hold one card for the same employer regardless of what type |
7 | | of dispensing organization license the employer holds. |
8 | | (i) Cannabis retail sales training requirements. |
9 | | (1) Within 90 days of September 1, 2019, or 90 days of |
10 | | employment, whichever is later, all owners, managers, |
11 | | employees, and agents involved in the handling or sale of |
12 | | cannabis or cannabis-infused product employed by an adult |
13 | | use dispensing organization or medical cannabis dispensing |
14 | | organization as defined in Section 10 of the Compassionate |
15 | | Use of Medical Cannabis Program Act shall attend and |
16 | | successfully complete a Responsible Vendor Program. |
17 | | (2) Each owner, manager, employee, and agent of an |
18 | | adult use dispensing organization or medical cannabis |
19 | | dispensing organization shall successfully complete the |
20 | | program annually. |
21 | | (3) Responsible Vendor Program Training modules shall |
22 | | include at least 2 hours of instruction time approved by |
23 | | the Department including: |
24 | | (i) Health and safety concerns of cannabis use, |
25 | | including the responsible use of cannabis, its |
26 | | physical effects, onset of physiological effects, |
|
| | SB3797 | - 15 - | LRB103 38981 CES 69118 b |
|
|
1 | | recognizing signs of impairment, and appropriate |
2 | | responses in the event of overconsumption. |
3 | | (ii) Training on laws and regulations on driving |
4 | | while under the influence and operating a watercraft |
5 | | or snowmobile while under the influence. |
6 | | (iii) Sales to minors prohibition. Training shall |
7 | | cover all relevant Illinois laws and rules. |
8 | | (iv) Quantity limitations on sales to purchasers. |
9 | | Training shall cover all relevant Illinois laws and |
10 | | rules. |
11 | | (v) Acceptable forms of identification. Training |
12 | | shall include: |
13 | | (I) How to check identification; and |
14 | | (II) Common mistakes made in verification; |
15 | | (vi) Safe storage of cannabis; |
16 | | (vii) Compliance with all inventory tracking |
17 | | system regulations; |
18 | | (viii) Waste handling, management, and disposal; |
19 | | (ix) Health and safety standards; |
20 | | (x) Maintenance of records; |
21 | | (xi) Security and surveillance requirements; |
22 | | (xii) Permitting inspections by State and local |
23 | | licensing and enforcement authorities; |
24 | | (xiii) Privacy issues; |
25 | | (xiv) Packaging and labeling requirement for sales |
26 | | to purchasers; and |
|
| | SB3797 | - 16 - | LRB103 38981 CES 69118 b |
|
|
1 | | (xv) Other areas as determined by rule. |
2 | | (j) Blank. |
3 | | (k) Upon the successful completion of the Responsible |
4 | | Vendor Program, the provider shall deliver proof of completion |
5 | | either through mail or electronic communication to the |
6 | | dispensing organization, which shall retain a copy of the |
7 | | certificate. |
8 | | (l) The license of a dispensing organization or medical |
9 | | cannabis dispensing organization whose owners, managers, |
10 | | employees, or agents fail to comply with this Section may be |
11 | | suspended or permanently revoked under Section 15-145 or may |
12 | | face other disciplinary action. |
13 | | (m) The regulation of dispensing organization and medical |
14 | | cannabis dispensing employer and employee training is an |
15 | | exclusive function of the State, and regulation by a unit of |
16 | | local government, including a home rule unit, is prohibited. |
17 | | This subsection (m) is a denial and limitation of home rule |
18 | | powers and functions under subsection (h) of Section 6 of |
19 | | Article VII of the Illinois Constitution. |
20 | | (n) Persons seeking Department approval to offer the |
21 | | training required by paragraph (3) of subsection (i) may apply |
22 | | for such approval between August 1 and August 15 of each |
23 | | odd-numbered year in a manner prescribed by the Department. |
24 | | (o) Persons seeking Department approval to offer the |
25 | | training required by paragraph (3) of subsection (i) shall |
26 | | submit a nonrefundable application fee of $2,000 to be |
|
| | SB3797 | - 17 - | LRB103 38981 CES 69118 b |
|
|
1 | | deposited into the Cannabis Regulation Fund or a fee as may be |
2 | | set by rule. Any changes made to the training module shall be |
3 | | approved by the Department. |
4 | | (p) The Department shall not unreasonably deny approval of |
5 | | a training module that meets all the requirements of paragraph |
6 | | (3) of subsection (i). A denial of approval shall include a |
7 | | detailed description of the reasons for the denial. |
8 | | (q) Any person approved to provide the training required |
9 | | by paragraph (3) of subsection (i) shall submit an application |
10 | | for re-approval between August 1 and August 15 of each |
11 | | odd-numbered year and include a nonrefundable application fee |
12 | | of $2,000 to be deposited into the Cannabis Regulation Fund or |
13 | | a fee as may be set by rule. |
14 | | (r) All persons applying to become or renewing their |
15 | | registrations to be agents, including agents-in-charge and |
16 | | principal officers, shall disclose any disciplinary action |
17 | | taken against them that may have occurred in Illinois, another |
18 | | state, or another country in relation to their employment at a |
19 | | cannabis business establishment or at any cannabis cultivation |
20 | | center, processor, infuser, dispensary, or other cannabis |
21 | | business establishment. |
22 | | (s) An agent applicant may begin employment at a |
23 | | dispensing organization while the agent applicant's |
24 | | identification card application is pending. Upon approval, the |
25 | | Department shall issue the agent's identification card to the |
26 | | agent. If denied, the dispensing organization and the agent |
|
| | SB3797 | - 18 - | LRB103 38981 CES 69118 b |
|
|
1 | | applicant shall be notified and the agent applicant must cease |
2 | | all activity at the dispensing organization immediately. |
3 | | (t) All notifications of acceptance or denial for |
4 | | applications under this Section shall be sent directly to the |
5 | | agent applicant. |
6 | | (Source: P.A. 101-27, eff. 6-25-19; 101-593, eff. 12-4-19; |
7 | | 102-98, eff. 7-15-21; 102-538, eff. 8-20-21; 102-813, eff. |
8 | | 5-13-22.) |
9 | | (410 ILCS 130/100 rep.) |
10 | | (410 ILCS 130/120 rep.) |
11 | | Section 20. The Compassionate Use of Medical Cannabis |
12 | | Program Act is amended by repealing Sections 100 and 120. |